Picture of VivoSim Labs logo

VIVS — VivoSim Labs News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Organovo and Viscient Biosciences collaborate to develop custom research platform for studying liver disease

Nov 6 (Reuters) - Organovo Holdings Inc  ONVO.O : 
    * Organovo and Viscient Biosciences collaborate to develop 
custom 
research platform for studying liver disease 
    * Says Viscient is targeting early discovery work for 
non-alcoholic fatty liver disease and non-alcoholic 
steatohepatitis 
 
Source text for Eikon:  ID:nGNXOGQBNa  
Further company coverage:  ONVO.O  
 
 ((Bangalore.newsroom@thomsonreuters.com; ;))

Recent news on VivoSim Labs

See all news